Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
101.40    2.90 (2.94%)
Bid:
99.20
Ask:
101.40
Spread: 2.20 (2.218%)
Market Cap: £123.20m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

AUM update

7 Oct 2022 07:00

RNS Number : 0967C
Impax Asset Management Group plc
07 October 2022
Β 

Impax Asset Management Group plc

Β 

("Impax" or the "Company")

Β 

Q4 AUM update

Impax, the AIM listed specialist investor focused on the transition to a more sustainable economy, today provides an update on the development of its assets under discretionary and advisory management ("AUM") for the fourth and final quarter of its financial year.

Β 

On 30 September 2022, the Company's AUM totalled Β£35.7 billion, an increase of 3.3% for the quarter, which included net inflows of Β£606 million for the quarter. Over the 12 months of the Company's full financial year, despite total net inflows of Β£2.9 billion, the Company's AUM fell by 4.1%.

Β 

Ian Simm, Chief Executive, commented:

"Despite weak market sentiment, fuelled by rising inflation and geopolitical instability, Impax has continued to attract new business, recording positive net inflows in the second half of the financial year to 30 September, including in the most recent financial quarter, with notable progress in the United States and Asia-Pacific regions.

Β 

"Asset owners continue to be attracted to Impax's focus on the transition to a more sustainable economy, which includes renewable energy, energy efficiency, water and digital infrastructure, sectors that are responding positively to both near term and longer horizon economic trends."Β 

Β 

Figure 1 below sets out further details of the movements in the Company's AUM for the quarter ended 30 September 2022. Figure 2 shows the same breakdown for the full financial year ended 30 September 2022.

Β 

Figure 1: Movements in the Company's AUM for the quarter ended 30 September 2022.

Β 

AUM movement

3 months to

30 September 2022

Listed equities

Fixed

income

Private

markets

Total firm

Β£m

Β£m

Β£m

Β£m

Total AUM at

30 June 2022

Β 

32,787

1,274

490

34,551

Net flows

577

7

22

606

Market movement, FX and performance

436

73

8

518

Total AUM at

30 September 2022

33,801

1,354

521

35,676

Β 

Figure 2: Movements in the Company's AUM for the full year ended 30 September 2022.

Β 

AUM movement

FY to

30 September 2022

Listed equities

Fixed

income

Private

markets

Total firm

Β£m

Β£m

Β£m

Β£m

Total AUM at

30 September 2021

Β 

35,637

1,257

318

37,211

Net flows

2,634

62

191

2,887

Market movement, FX and performance

(4,470)

35

12

(4,423)

Total AUM at

30 September 2022

33,801

1,354

521

35,676

Β 

Β 

LEI number: 213800AJDNW4S2B7E680

Β 

- Ends -

Β 

Enquiries:

Β 

Impax Asset Management Group plc

Ian Simm, Chief Executive

Paul French, Head of Corporate Communications

Β 

+44 (0)20 3912 3000

+44 (0)20 3912 3032

Β 

Β 

Montfort Communications

Gay Collins

Jack Roddan

impax@montfort.london

Β 

Β 

Β 

Β 

+44 (0)77 9862 6282

+44 (0)78 2567 0695

Peel Hunt LLP, Nominated Adviser and Joint Broker

James Britton or Paul Shackleton

Β 

Berenberg, Joint Broker

Alex Reynolds

Β 

+44 (0)20 7418 8900

Β 

Β 

+44 (0)20 3207 7800

Β 

Notes to Editors - About Impax Asset Management

Β 

Founded in 1998, Impax is a specialist asset manager, with approximately Β£35.7 billion as of 30 September 2022 in both listed and private markets strategies, investing in the opportunities arising from the transition to a more sustainable global economy.

Β 

Impax believes that capital markets will be shaped profoundly by global sustainability challenges, including climate change, pollution and essential investments in human capital, infrastructure and resource efficiency. Impax believes that these trends will drive growth for well-positioned companies and create risks for those unable or unwilling to adapt.

Β 

The company seeks to invest in higher quality companies with strong business models that demonstrate sound management of risk. Impax offers a well-rounded suite of investment solutions spanning multiple asset classes seeking superior risk-adjusted returns over the medium to long term.

Β 

Impax has ca. 260 staff across its offices in the United Kingdom, the United States, Ireland and Hong Kong, making it one of the investment management sector's largest investment teams dedicated to sustainable development.

Β 

For further information please visit www.impaxam.com

Β 

Issued in the UK by Impax Asset Management Group plc, whose shares are quoted on the Alternative Investment Market of the London Stock Exchange.Β  Impax Asset Management Group plc is registered in England & Wales, number 03262305.Β  AUM relates to Impax Asset Management Limited, Impax Asset Management (AIFM) Limited, Impax Asset Management Ireland Limited and Impax Asset Management LLC. Impax Asset Management Limited and Impax Asset Management (AIFM) Limited are authorised and regulated by the Financial Conduct Authority and are wholly owned subsidiaries of Impax Asset Management Group plc. Please note that the information provided and links from it should not be relied upon for investment purposes.Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCZZMGGMVGGZZZ
Date   Source Headline
31st May 20237:00 amRNSHalf-year Report
26th May 20233:10 pmRNSInvestment Advisory Agreement
26th May 20237:00 amRNSHolding(s) in Company
23rd May 20237:00 amRNSInvestor Presentation of Interim Results
15th May 20232:25 pmRNSHolding(s) in Company
9th May 20237:00 amRNSNotice of Results
11th Apr 20237:00 amRNSQ2 AUM Update
16th Mar 20231:57 pmRNSDirectorate Changes
16th Mar 20231:56 pmRNSResult of AGM
15th Mar 20238:43 amRNSHolding(s) in Company
9th Jan 20237:00 amRNSQ1 AUM update
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20223:33 pmRNSHolding(s) in Company
16th Dec 20224:46 pmRNSNotice of AGM
13th Dec 20223:02 pmRNSHolding(s) in Company
1st Dec 20225:06 pmRNSPublication of Annual Financial Report
1st Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSFinal Results
25th Nov 20227:00 amRNSinvestor Presentation of Full Year Results
23rd Nov 20227:00 amRNSNotice of results
21st Nov 20225:05 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSAUM update
3rd Oct 20228:22 amRNSHolding(s) in Company
13th Sep 202210:49 amRNSHolding(s) in Company
9th Sep 20221:32 pmRNSHolding(s) in Company
2nd Sep 20223:34 pmRNSHolding(s) in Company
12th Aug 20229:37 amRNSDirector/PDMR Shareholding
21st Jul 20225:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSAUM update
6th Jul 20221:50 pmRNSDirector/PDMR and PCA Shareholding
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSBoard Appointment
16th Jun 20224:37 pmRNSDirector/PDMR and PCA Shareholding
14th Jun 20227:00 amRNSHolding(s) in Company
7th Jun 20224:36 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSInterim results to 31 March 2022
12th May 20228:16 amRNSHolding(s) in Company
12th May 20227:00 amRNSInvestor Presentation of Interim Results
6th May 20227:00 amRNSDate of Interim Results
26th Apr 20223:37 pmRNSHolding(s) in Company
20th Apr 20222:11 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSAUM update
30th Mar 20222:14 pmRNSDirector/PDMR Shareholding
29th Mar 20226:10 pmRNSResult of AGM
4th Mar 20222:30 pmRNSDirector/PDMR and PCA Shareholding
25th Feb 20227:00 amRNSAIM Rule 17 Schedule Two (g) Update
14th Feb 20221:24 pmRNSDistribution agreement
10th Jan 20227:00 amRNSAUM update
20th Dec 20216:04 pmRNSNotice of Annual General Meeting ("AGM")
20th Dec 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.